India rejects Pfizer's patent application for arthritis drug

Last Updated: Monday, September 7, 2015, 18:58

India's patent office has again rejected US drug major Pfizer's new patent application for its rheumatoid arthritis medicine, tofacitinib, citing it did not enhance the efficacy of the existing approved drug.

Pfizer lifts forecast despite hit from strong dollar

Last Updated: Tuesday, July 28, 2015, 18:39

Pfizer reported a dip in second-quarter profits Tuesday, but boosted its forecast due in part to higher revenues from cancer drugs and global vaccines.

Pfizer's June quarter net grows 43% to Rs 54 crore

Last Updated: Saturday, July 25, 2015, 21:05

Drug maker Pfizer on Saturday posted a 43.43 percent rise in its net profit at Rs 53.83 crore for the first quarter ended June.

Pfizer to close its Navi Mumbai plant

Last Updated: Wednesday, July 15, 2015, 14:44

Drug firm Pfizer is planning to close its Navi Mumbai plant from September 16, 2015.

Pfizer reports Q4 net profit at Rs 42.68 crore

Last Updated: Tuesday, May 5, 2015, 21:30

Drug firm Pfizer Tuesday reported a standalone net profit of Rs 42.68 crore for the quarter ended March 31, 2015.

Investors seek protection against healthcare stock decline

Last Updated: Saturday, April 25, 2015, 01:45

Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

Pfizer stops sale of children's vaccine in China

Last Updated: Saturday, April 4, 2015, 13:36

American pharmaceutical giant Pfizer has stopped selling one of its lucrative vaccines for children in China, the company said.

Pfizer to acquire Hospira at enterprise value of $17 bn

Last Updated: Thursday, February 5, 2015, 19:19

This is Pfizer's biggest acquisition after its failed USD 117 billion takeover bid for UK-based pharmaceuticals firm AstraZeneca in May last year.

U.S. multinationals hit hard by strong dollar, to bleed further into 2015

Last Updated: Wednesday, January 28, 2015, 04:40

A slew of U.S. multinational companies, from DuPont to Procter & Gamble, showed that a strong U.S. dollar hurt their earnings, and several blue-chip exporters said the situation will get worse if the greenback holds its strength.

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bn

Last Updated: Tuesday, January 27, 2015, 09:00

Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday.

Ranbaxy gets Health Canada nod for generic anti-dementia drug

Last Updated: Wednesday, January 8, 2014, 19:13

Drug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept, a drug used for treatment of dementia in Alzheimer's patients.